End-site-specific conjugation of enoxaparin and tetradeoxycholic acid using nonenzymatic glycosylation for oral delivery
This was a specific complaint from some customers, where formulation changes led to different responses
"Some patients will end up on them for most of their lives, and thats okay," says Christine Lovato, MD, a bariatric surgeon at Banner University Medical Center in Phoenix
In markets across Asia, Africa, Latin America, and parts of Eastern Europe where cold-chain infrastructure is unreliable, oral GLP-1s have the potential to unlock access to hundreds of millions of patients who could never have reliably received injectable therapy
Additionally, GLP-1 reduces the release of glucagon, another hormone produced by the pancreas, which typically signals the liver to release stored glucose